Founders Financial Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $514K | Sell |
1,155
-12
| -1% | -$5.34K | 0.04% | 340 |
|
|
2025
Q1 | $579K | Buy |
1,167
+20
| +2% | +$9.93K | 0.05% | 296 |
|
|
2024
Q4 | $462K | Buy |
1,147
+34
| +3% | +$13.7K | 0.04% | 319 |
|
|
2024
Q3 | $518K | Sell |
1,113
-146
| -12% | -$67.9K | 0.05% | 268 |
|
|
2024
Q2 | $590K | Buy |
1,259
+73
| +6% | +$34.2K | 0.06% | 258 |
|
|
2024
Q1 | $496K | Buy |
1,186
+184
| +18% | +$76.9K | 0.05% | 264 |
|
|
2023
Q4 | $408K | Buy |
1,002
+28
| +3% | +$11.4K | 0.05% | 272 |
|
|
2023
Q3 | $339K | Buy |
974
+73
| +8% | +$25.4K | 0.04% | 252 |
|
|
2023
Q2 | $317K | Buy |
901
+167
| +23% | +$58.8K | 0.04% | 257 |
|
|
2023
Q1 | $231K | Hold |
734
| – | – | 0.03% | 283 |
|
|
2022
Q4 | $212K | Sell |
734
-68
| -8% | -$19.6K | 0.03% | 300 |
|
|
2022
Q3 | $232K | Sell |
802
-57
| -7% | -$16.5K | 0.04% | 271 |
|
|
2022
Q2 | $242K | Sell |
859
-304
| -26% | -$85.6K | 0.05% | 222 |
|
|
2022
Q1 | $304K | Buy |
1,163
+112
| +11% | +$29.3K | 0.05% | 215 |
|
|
2021
Q4 | $231K | Buy |
+1,051
| New | +$231K | 0.04% | 235 |
|
|
2021
Q3 | – | Sell |
-997
| Closed | -$201K | – | 305 |
|
|
2021
Q2 | $201K | Buy |
+997
| New | +$201K | 0.04% | 284 |
|